A recent study indicates that individuals who discontinue new slimming jabs like semaglutide or tirzepatide can put back on reduced body mass far faster than those who end traditional lifestyle programs.
Published data in a leading medical journal demonstrates that while obese people can lose substantial amounts of their body weight while undergoing treatment, the weight returns at an average rate of nearly a kilo each month once they quit.
"Users purchasing these treatments should be aware of the danger of rapid rebound weight gain when the medication ends," stated lead investigator Dr. Susan Jebb.
That rate of recovery implies a reversion to starting weight in about a year and a half.
Analyzing Treatments
The analysis, which examined dozens of studies involving over 9,000 of patients, contrasted the effects of these new drugs with conventional dieting.
Scientists note that individuals who lose weight through lifestyle changes alone generally see a less rapid creep back—approximately 0.1 kg a month—once they finish.
Understanding the Rapid Regain
Experts believe the mode of action of the injections explains the heightened weight return.
These medications mimic a natural hormone called GLP-1, which controls appetite.
"Sustained high doses of GLP-1 levels several times higher than the body's typical production may cause the body to generate a reduced amount of its endogenous hormone, and could lessen sensitivity to its effects," explained Dr. Adam Collins, a dietetics specialist.
"Stopping of this medication results in hunger is uncontrolled, making binge eating much more probable."
A Chronic Issue?
Medical guidelines recommend the injections for people with weight-linked health risks, alongside prescribed diet and exercise modifications.
A number of clinicians argue that, considering the likelihood of weight regain, the treatment might need to be long-term.
This opinion is reinforced by pharmaceutical companies, who say that the findings "emphasize the persistent character of obesity," akin to managing diseases like hypertension.
User Accounts
Individuals who have stopped the jabs explain a powerful resurgence of hunger.
"It was like something that goes on and you're instantly ravenous," recalled an individual.
This challenge is worsened if patients have not established sustainable dietary or behavioural modifications during therapy.
Significant Use
Survey data suggest that a significant number of adults in the UK have used weight-loss jabs in the last 12 months, with desire being substantial.
- Adoption is greater among females than males.
- The 40s and 50s age group shows the greatest usage rates.
- A large proportion access the drugs through private prescriptions rather than public health services.
Finally, clinicians emphasize that while these medications are effective tools for weight loss, they are not a standalone cure and long-term success hinges on integrated lifestyle changes.